Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05872295
Title IKS014 in Advanced Solid Tumors That Express HER2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Iksuda Therapeutics Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.